Beta Agonist Feed Additive Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Beta-Agonist Feed Additive Market Report Has Been Segmented by Type (Zilpaterol and Ractopamine), by Animal Type (Ruminants, Swine, and More), and by Geography (North America, Asia-Pacific, South America, and More). The Report Offers Market Size and Forecasts in Value (USD).

Beta Agonist Feed Additive Market Size and Share

Beta Agonist Feed Additive Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Benchmark Beta Agonist Feed Additive Against Other Animal Nutrition & Wellness Markets

Beta Agonist Feed Additive Market Analysis by Mordor Intelligence

The beta agonist feed additive market size is expected to increase from USD 1.27 billion in 2026 to USD 1.34 billion in 2027 and reach USD 1.79 billion by 2032, growing at a CAGR of 5.96% over 2027-2032. The beta-agonist feed additive market is experiencing robust growth, driven by increasing demand for high-quality meat production, improved animal growth performance, and enhanced feed efficiency. Widely utilized in the livestock industry, particularly in cattle and swine farming, beta-agonists help promote lean muscle growth, reduce fat deposition, and optimize feed utilization. The rising production of livestock is a key factor fueling market growth. For instance, the United States swine production increased from 75.0 million in 2022 to 75.8 million in 2023, according to FAOSTAT. Similarly, growing meat consumption has led to higher meat production in countries such as China, the United States, and Argentina. FAOSTAT data indicates that global beef production rose from 75.4 million metric tons in 2022 to 76.6 million metric tons in 2023. As demand for meat continues to surge, especially in emerging economies, livestock producers are increasingly adopting cost-effective solutions to enhance productivity and meet market needs. Furthermore, rising investments in precision livestock farming are contributing to the market’s expansion, creating new opportunities for industry players.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

Market Concentration

Beta Agonist Feed Additive Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The beta-agonist feed additives market is consolidated, with few major players offering similar products. The limited scope for product differentiation and innovation has resulted in a concentrated competitive landscape. Some of the major players in the country include Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feed, and Heer Pharma Private Limited. New product launches following extensive R&D activities have been part of the strategic moves by the players.

Beta Agonist Feed Additive Industry Leaders

  1. Merck Animal Health

  2. Elanco Animal Health

  3. Zoetis

  4. Quality Liquid Feeds

  5. Heer Pharma Private Limited

  6. *Disclaimer: Major Players sorted in no particular order

Beta Agonist Feed Additive Market Companies Covered in this Report

  • Merck Animal Health
  • Elanco Animal Health
  • Zoetis
  • Quality Liquid Feeds
  • Heer Pharma Private Limited

Read Analysis of Beta Agonist Feed Additive Companies

Recent Industry Developments in Beta Agonist Feed Additive Market

  • March 2024: The Animal Legal Defense Fund, Center for Biological Diversity, Center for Food Safety, and Food Animal Concerns Trust filed a lawsuit requiring the U.S. Food and Drug Administration (FDA) to respond to their 2012 and 2020 rulemaking petitions. These petitions called for reducing or eliminating permitted ractopamine levels in farmed animals.

Table of Contents for Beta Agonist Feed Additive Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Animal Meat
    • 4.2.2 Growing Market for Protein-based foods
    • 4.2.3 Growing Awareness of Animal Health and Welfare
  • 4.3 Market Restraints
    • 4.3.1 The High Cost of Beta Agonist Feed Additives
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Powers of Buyers
    • 4.4.2 Bargaining Powers of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Ractopamine
    • 5.1.2 Zilpaterol
  • 5.2 Animal Type
    • 5.2.1 Swine
    • 5.2.2 Ruminants
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.1.4 Rest of North America
    • 5.3.2 Asia-Pacific
    • 5.3.2.1 Japan
    • 5.3.2.2 South Korea
    • 5.3.2.3 India
    • 5.3.2.4 Rest of Asia-Pacific
    • 5.3.3 South America
    • 5.3.3.1 Brazil
    • 5.3.3.2 Argentina
    • 5.3.3.3 Rest of South America
    • 5.3.4 Rest of the World

6. COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles
    • 6.3.1 Merck Animal Health
    • 6.3.2 Elanco Animal Health
    • 6.3.3 Zoetis
    • 6.3.4 Quality Liquid Feeds
    • 6.3.5 Heer Pharma Private Limited
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Global Beta Agonist Feed Additive Market Report Scope

Beta-agonists are used as feed additives for ruminants and swine, especially before slaughter. They are approved feed additives, which help in escalating lean muscle gain, increasing growth rate, and improving feed efficiency. The Beta-Agonist Feed Additive Market Report Has Been Segmented by Type (Zilpaterol and Ractopamine), by Animal Type (Ruminants, Swine, and More), and by Geography (North America, Asia-Pacific, South America, and More). The Report Offers Market Size and Forecasts in Value (USD).

Segmentation Overview

Type
Beta Agonist Feed Additive Market segmentation breakdown
Ractopamine
Zilpaterol
Animal Type
Beta Agonist Feed Additive Market segmentation breakdown
Swine
Ruminants
Others
Geography
Beta Agonist Feed Additive Market segmentation breakdown
North America United States
Canada
Mexico
Rest of North America
Asia-Pacific Japan
South Korea
India
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Rest of the World
Beta Agonist Feed Additive Market segmentation breakdown
Type Ractopamine
Zilpaterol
Animal Type Swine
Ruminants
Others
Geography North America United States
Canada
Mexico
Rest of North America
Asia-Pacific Japan
South Korea
India
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Rest of the World

Key Questions Answered in the Report

How big is the Beta Agonist Feed Additive Market?

The Beta Agonist Feed Additive Market size is projected to reach USD 1.34 billion in 2027 and grow at a CAGR of 5.96% to reach USD 1.79 billion by 2032.

What is the Beta Agonist Feed Additive Market size in 2026?

In 2026, the Beta Agonist Feed Additive Market size is projected to reach USD 1.27 billion.

Who are the key players in Beta Agonist Feed Additive Market?

Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.

Which is the fastest growing region in Beta Agonist Feed Additive Market?

Asia Pacific is the fastest growing region, forecast to grow at a CAGR of 7.2% from 2027 to 2032.

Which region has the biggest share in Beta Agonist Feed Additive Market?

In 2026, the North America accounts for the largest market share in Beta Agonist Feed Additive Market.

Page last updated on: